De-Risky Business: Assessing Biotherapeutic Off-Target and On-Target Liabilities
Sponsor: Integral Molecular
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Sponsor: 3DS Dassault Systemes
Cancer Gene Expression Targets Validated Using Novel Histopathology Tools
Sponsor: ACD: A bio-techne brand
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.